BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 16213307)

  • 1. Malignancy in renal recipients.
    Samhan M; Al-Mousawi M; Donia F; Fathi T; Nasim J; Nampoory MR
    Transplant Proc; 2005 Sep; 37(7):3068-70. PubMed ID: 16213307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of malignancy following living donor kidney transplantation.
    Nafar M; Einollahi B; Hemati K; Gholi FP; Firouzan A
    Transplant Proc; 2005 Sep; 37(7):3065-7. PubMed ID: 16213306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.
    Ju MK; Joo DJ; Kim SJ; Huh KH; Kim MS; Jeon KO; Kim HJ; Kim SI; Kim YS
    Transpl Int; 2009 Jun; 22(6):644-53. PubMed ID: 19220824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin malignancies in renal transplant recipients: a Brazilian center registry.
    Falsarella PM; Alves-Filho G; Mazzali M
    Transplant Proc; 2008 Apr; 40(3):767-8. PubMed ID: 18455011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies.
    Boratyńska M; Watorek E; Smolska D; Patrzałek D; Klinger M
    Transplant Proc; 2007 Nov; 39(9):2736-9. PubMed ID: 18021973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kaposi's sarcoma in Sudanese renal transplant recipients: a report from a single center.
    Sabeel AI; Qunibi WY; Alfurayh OA; Al-Meshari K
    J Nephrol; 2003; 16(3):412-6. PubMed ID: 12832743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and types of malignancies in renal transplant recipients in Iraq.
    Altaee IK; Jaleel NA; Aljubury HM; Alshamaa IA; Gazala S
    Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):408-14. PubMed ID: 16970265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaposi's sarcoma in organ transplant recipients. The Collaborative Transplantation Research Group of Ile de France.
    Farge D
    Eur J Med; 1993; 2(6):339-43. PubMed ID: 8252179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early de novo malignancies after kidney transplantation.
    Veroux M; Puliatti C; Fiamingo P; Cappello D; Macarone M; Puliatti D; Vizcarra D; Gagliano M; Veroux P
    Transplant Proc; 2004 Apr; 36(3):718-20. PubMed ID: 15110643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urological malignancy as a complication of renal transplantation: a report of twelve clinical cases.
    Zhou M; Zhu Y; Wang L; Wang Y; Fu S; Min Z
    Clin Transpl; 2006; ():395-8. PubMed ID: 18365395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo malignancies after renal transplantation--a single-center experience in the Balkans.
    Popov Z; Ivanovski O; Kolevski P; Stankov O; Petrovski D; Cakalaroski K; Ivanovski N
    Transplant Proc; 2007 Oct; 39(8):2589-91. PubMed ID: 17954184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi's sarcoma in renal transplant patients: predisposing factors and prognosis.
    Berber I; Altaca G; Aydin C; Dural A; Kara VM; Yigit B; Turkmen A; Titiz MI
    Transplant Proc; 2005 Mar; 37(2):967-8. PubMed ID: 15848593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive therapy and Kaposi's sarcoma after kidney transplantation.
    Moray G; Başaran O; Yağmurdur MC; Emiroğlu R; Bilgin N; Haberal M
    Transplant Proc; 2004; 36(1):168-70. PubMed ID: 15013336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma in renal transplant recipients.
    Chuang CH; Chien YS; Cheng YT; Chen YT; Hu TH; Hsieh H
    Transplant Proc; 2008 Sep; 40(7):2392-4. PubMed ID: 18790244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo malignances in pediatric organ transplant recipients.
    Penn I
    Pediatr Transplant; 1998 Feb; 2(1):56-63. PubMed ID: 10084762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of Kaposi's sarcoma and graft following discontinuation of immunosuppressive drugs in renal transplant recipients.
    Firoozan A; Hosseini Moghaddam SM; Einollahi B; Pour-Reza-Gholi F; Nafar M; Basiri A; Ebrahimi-Rad R
    Transplant Proc; 2005 Sep; 37(7):3061-4. PubMed ID: 16213305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttransplantation lymphoproliferative disorders in renal transplant recipients: report of over 20 years of experience.
    Saadat A; Einollahi B; Ahmadzad-Asl MA; Moradi M; Nafar M; Pourfarziani V; Firoozan A; Porrezagholi F; Davoudi F
    Transplant Proc; 2007 May; 39(4):1071-3. PubMed ID: 17524894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area.
    Cuellar-Rodriguez J; Avery RK; Lard M; Budev M; Gordon SM; Shrestha NK; van Duin D; Oethinger M; Mawhorter SD
    Clin Infect Dis; 2009 Sep; 49(5):710-6. PubMed ID: 19635026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of kidney transplantation in recipients 60 years of age and older at the University of Florida.
    Foley DP; Patton PR; Meier-Kriesche HU; Li Q; Shenkman B; Fujita S; Reed A; Hemming AW; Kim RD; Howard RJ
    Clin Transpl; 2005; ():101-9. PubMed ID: 17424728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of posttransplantation malignancies compared with de novo tumors.
    Haberal AN; Süren D; Demirhan B; Bilezikçi B; Celasun B; Haberal M
    Transplant Proc; 2007 May; 39(4):1057-62. PubMed ID: 17524891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.